Progressive Pulmonary Fibrosis - CPL | US
Offer Details: | |
|---|---|
| Offer Name: | Progressive Pulmonary Fibrosis - CPL | US |
| Payout: | $28.00 / CPA |
| Preview: | Preview Landing Page |
| Categories: | Ecommerce |
| Network: | DYNU IN MEDIA |
| Last Updated: | May 22, 2025 |
| Countries: | US |
Ages: 21+
Study Description: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat symptoms associated with Progressive Pulmonary Fibrosis. You may be asked to attend 1 or more screening visits to determine if you are eligible to enroll in the study. If enrolled, you will receive either the oral medication being tested in this study or a placebo to be taken twice a day. The treatment period will last a minimum of 1 year and up to approximately 3 years and you will be asked to attend regular doctor’s visits. During these visits, you will complete various diagnostic tests, including a CT scan of your lungs, lung function tests, and blood sample collection for laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Qualifications:
- Must already be diagnosed with Interstitial Lung Disease (ILD) or Progressive Pulmonary Fibrosis
- Cannot be diagnosed with Idiopathic Pulmonary Fibrosis
- Cannot have had a lung transplant
- Cannot be diagnosed with Congestive Heart Failure
PROOF REQUIRED
Mailer Access: Key: https://www.affiliateaccesskey.com/m-dzkm-s96-408d87cf2deb179a4d01cfee5fc95d11
Optout Link: https://www.twonailhall.com/o-dzkm-s96-ea5092831cdcd7d9d4b7369251968ce6
Study Description: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat symptoms associated with Progressive Pulmonary Fibrosis. You may be asked to attend 1 or more screening visits to determine if you are eligible to enroll in the study. If enrolled, you will receive either the oral medication being tested in this study or a placebo to be taken twice a day. The treatment period will last a minimum of 1 year and up to approximately 3 years and you will be asked to attend regular doctor’s visits. During these visits, you will complete various diagnostic tests, including a CT scan of your lungs, lung function tests, and blood sample collection for laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Qualifications:
- Must already be diagnosed with Interstitial Lung Disease (ILD) or Progressive Pulmonary Fibrosis
- Cannot be diagnosed with Idiopathic Pulmonary Fibrosis
- Cannot have had a lung transplant
- Cannot be diagnosed with Congestive Heart Failure
PROOF REQUIRED
Mailer Access: Key: https://www.affiliateaccesskey.com/m-dzkm-s96-408d87cf2deb179a4d01cfee5fc95d11
Optout Link: https://www.twonailhall.com/o-dzkm-s96-ea5092831cdcd7d9d4b7369251968ce6
DYNU IN MEDIA
DYNU IN MEDIA is a super match CPA/CPL network for earning money online that provides you with all techniques allowing you to monetize your traffic in all channels. We guarantee outstanding support to our publishers. Our devoted team with experience in the affiliate marketing industry will give you full-assist, direct offers in a wide-ranging variety of verticals and top GEOs, and a flexible payment schedule of NET15 & NET30. Hitting more than 20,000 leads generated daily for over 200 influential clients, along with an increasing number of HQ publishers to 300 and more, DYNU IN MEDIA is taking high pride in our professionalism and high integrity.
